Verona Pharma plc Contracts & Agreements
14 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (2)
- Human Resources (2)
- Real Estate (3)
- Uncategorized (2)
- Verona Pharma plc Second Amended and Restated 2017 Incentive Award Plan (Filed With SEC on May 1, 2023)
- Loan and Security Agreement, dated as of October 14, 2022, by and among Verona Pharma plc, Verona Pharma, Inc., Oxford Finance Luxembourg S. R.L., as collateral agent and as a... (Filed With SEC on October 17, 2022)
- Underwriting Agreement, dated as of August 10, 2022, by and among Verona Pharma plc, Jefferies LLC, Piper Sandler & Co. and Truist Securities, Inc., as representatives of the... (Filed With SEC on August 12, 2022)
- Second Amendment to Loan and Security Agreement, dated as of March 2, 2022, by and among Silicon Valley Bank, Verona Pharma plc and Verona Pharma, Inc (Filed With SEC on May 3, 2022)
- Amendment Agreement by and between Verona Pharma plc and Ligand UK Development Limited dated March 24, 2022 (Filed With SEC on March 30, 2022)
- Renewal Agreement to Lease by and between the Verona Pharma Plc. and Regus Management (UK) Limited dated November 9, 2021 (Filed With SEC on March 3, 2022)
- Renewal Agreement to Lease by and between the Verona Pharma Plc. and Regus Management (UK) Limited dated December 7, 2021 (Filed With SEC on March 3, 2022)
- Agreement to Lease by and between the Verona Pharma Inc. and Brier Creek Office #4, LLC dated March 6, 2020 (Filed With SEC on March 3, 2022)
- Second Amendment to Loan and Security Agreement, dated as of March 2, 2022, by and among Silicon Valley Bank, Verona Pharma plc and Verona Pharma, Inc (Filed With SEC on March 3, 2022)
- Verona Pharma plc Employee Change in Control Severance Benefit Plan (Filed With SEC on August 11, 2021)
- Collaboration and License Agreement, effective as of June 9, 2021, by and between Verona Pharma plc, Nuance Pharma Limited and Nuance (Shanghai) Pharma Co Ltd (Filed With SEC on August 5, 2021)
- Description of Securities (Filed With SEC on February 25, 2021)
- Form of Non-Executive Director letter of appointment (Filed With SEC on February 25, 2021)
- First Amendment to Loan and Security Agreement, dated as of November 19, 2020, by and among Silicon Valley Bank, Verona Pharma plc and Verona Pharma, Inc (Filed With SEC on February 25, 2021)
